PATENT CLAIM ANALYSIS

Application Number: 16176338
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "468000"]

Abstract:
The instant invention is generally directed to a patient-friendly drug delivery system for targeted populations, such as pediatric and geriatric patients. Specifically, the present invention relates to a pharmaceutical composition in the form of mini-tablets. Even more specifically, the present invention relates to a pharmaceutical composition comprising a therapeutically-effective amount of melatonin in the form of mini-tablets.

Claim (Index 1):
A controlled-release melatonin mini-tablet comprising:\n a therapeutically effective amount of melatonin; and one or more pharmaceutically acceptable carriers;\n wherein the mini-tablet has a diameter of less than or equal to 4 mm and has a release profile of less than 50% melatonin release within 1 hour, and about greater than 70% melatonin release within 6 hours.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.575
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14482160', '12144453', '10269551', '14383462', '10895984']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7213619685359016
- 35 USC 102 Novelty (BERT): 0.5043572588419958
- Combined Prediction Score: 0.699661497566511
- Mean Citation Score: 230.050276
- Max Citation Score: 244.61156
- Similarity Product: 177.62224362781524

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test